DNA, RNA and Protein Synthesis Other
| Cat. No. | Product Name / Activity |
|---|---|
| 6602 | 1M7 |
| Reagent for RNA SHAPE-MaP chemistry | |
| 7376 | 2A3 |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable | |
| 3771 | Azithromycin |
| Antibiotic; inhibits 50S ribosomal subunit formation and elongation at transpeptidation | |
| 5015 | 5-BrdU |
| Synthetic thymidine analog; used for cell proliferation assays | |
| 8108 | CEP |
| Chemoproteomic reagent, clickable electrophilic purine for RNA binding profiling in live cells | |
| 4091 | Cyclophosphamide |
| Alkylating agent; chemotherapeutic | |
| 4090 | Doxycycline hyclate |
| Regulator for inducible gene expression systems; also broad-spectrum antibiotic and MMP inhibitor | |
| 7207 | 5-Ethynyl-2'-deoxyuridine |
| Thymidine analog for labeling DNA; can be linked to a fluorophore by click chemistry | |
| 7206 | 5-Ethynyluridine |
| Uridine analog, used for labeling RNA synthesis | |
| 5075 | Harmine |
| Binds to the yjdF aptamer; activates riboswitch function; also DYRK1A inhibitor | |
| 6782 | Indisulam |
| Pre-mRNA splicing modulator; hCA XII inhibitor | |
| 5284 | trans-ISRIB |
| Integrated stress response (ISR) inhibitor | |
| 5185 | JTE 607 dihydrochloride |
| Active metabolite binds CPSF3; Pro-drug | |
| 7942 | Lac-Phe |
| Metabolite generated by cytosol nonspecific dipeptidase (CNDP2) during intense exercise | |
| 7586 | Molnupiravir |
| Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection | |
| 7974 | P3S |
| Reagent for modifying RNA at 2'-OH position, for SHAPE-MAP experiments | |
| 6862 | Psoralen-triethylene glycol azide |
| RNA conformation probe; reagent for COMRADES RNA platform | |
| 7916 | Risdiplam |
| Selective SMN2 gene splicing modifier |

